Pulmonary Arterial Hypertension is a serious condition that damages pulmonary blood vessels. With proper treatment only 60% of PAH patients survive beyond 5 years of diagnosis. Dr. Zamanian treats people with PAH at Stanford’s Vera Moulton Wall Center for Pulmonary Vascular Disease. I found this tree while scouting for backgrounds. I immediately thought of the…